Corporate Board Profile
Tech Score: 100/100
1 mention(s) identify ROHIN MHATRE, PH.D. as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| REPLIGEN CORP | 2025-04-04 | Dr. Mhatre holds a Ph.D. in Chemistry from Northeastern University. Dr. Mhatre’s qualifications to sit on the Board include his extensive technical expertise, his leadership abilities and his deep understanding of the dependencies between biological drug development and efficient manufacturing workflows. | He holds a Ph.D. in Chemistry and has extensive technical expertise in biopharmaceutical development, including leading teams responsible for cell line, cell culture, purification, and device development, indicating strong technical and scientific skills that likely include programming or software-related expertise. |
| Filing Date | Source Excerpt |
|---|---|
| 2025-04-04 | Dr. Mhatre holds a Ph.D. in Chemistry from Northeastern University. Dr. Mhatre’s qualifications to sit on the Board include his extensive technical expertise, his leadership abilities and his deep understanding of the dependencies between biological drug development and efficient manufacturing workflows. |
Data sourced from SEC filings. Last updated: 2025-07-01